NGM
Ngm Biopharmaceuticals Inc
$1.54
Earnings Summary
Revenue | $0.17Mn |
Net Profits | $-27.67Mn |
Net Profit Margins | -16769.7% |
Highlights
Ngm Biopharmaceuticals Inc’s revenue fell -99.09% since last year same period to $0.17Mn in the Q4 2023. On a quarterly growth basis, Ngm Biopharmaceuticals Inc has generated -71.65% fall in its revenue since last 3-months.
Ngm Biopharmaceuticals Inc’s net profit jumped 19.98% since last year same period to $-27.67Mn in the Q4 2023. On a quarterly growth basis, Ngm Biopharmaceuticals Inc has generated 3.91% jump in its net profits since last 3-months.
Ngm Biopharmaceuticals Inc’s net profit margin fell -8717.71% since last year same period to -16769.7% in the Q4 2023. On a quarterly growth basis, Ngm Biopharmaceuticals Inc has generated -238.92% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ngm Biopharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.38 |
EPS Estimate Current Year | -0.38 |
Highlights
Ngm Biopharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.38 - a 2.56% jump from last quarter’s estimates.
Ngm Biopharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.38.
Key Ratios
Key ratios of the Ngm Biopharmaceuticals Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.33 |
Highlights
Ngm Biopharmaceuticals Inc’s earning per share (EPS) jumped 26.67% since last year same period to -0.33 in the Q4 2023. This indicates that the Ngm Biopharmaceuticals Inc has generated 26.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -0.42 | -0.35 | 16.67% |
2024-03-11 | -0.39 | -0.33 | 15.38% |
2023-05-04 | -0.52 | -0.58 | -11.54% |
2023-08-03 | -0.5 | -0.46 | 8% |
₹0 US Stocks a/c Opening Fee